GHK-Cu for perimenopause hair loss: what the evidence actually shows

What did @laurenlewisfhcc actually say?

The creator claims copper peptides, specifically GHK-Cu, are a go-to solution for perimenopausal hair loss. She says they "strengthen the strands you already have," improve scalp circulation, and most boldly, "wake up dead follicles to encourage new growth." That last phrase is the one worth examining closely, because dead and dormant are not the same thing, and the distinction matters a lot when you're deciding whether to spend money on a peptide.

The video is framed as a reply to a viewer question, which gives it a personal, advice-driven tone. There's no mention of consulting a doctor, checking hormone levels, or ruling out other causes of hair thinning. It's presented as a clean, self-contained fix. That framing is worth keeping in mind as you read further.

Does the science back this up?

Partially, yes. GHK-Cu has real research behind it, more than most peptides being promoted on TikTok right now. The evidence is not conclusive, but it's not nothing either.

A study by Pickart et al. (2015, Journal of Aging Science) identified GHK-Cu as a signaling molecule that declines significantly with age and influences tissue repair processes including skin and follicle regeneration. Separate in vitro research published by Husain et al. (2021, Biomolecules) found GHK-Cu stimulated keratinocyte proliferation and increased expression of genes associated with hair follicle cycling. A smaller clinical study by Jourdan et al. (1990s, Skin Pharmacology) showed topical GHK-Cu application increased follicle size in some participants. The scalp circulation claim also has some biological plausibility, since GHK-Cu has demonstrated pro-angiogenic effects in wound healing models. None of these studies were large randomized controlled trials specifically in perimenopausal women, and that gap is significant.

What did they get wrong (or right)?

The claim about waking up "dead follicles" is the biggest problem here. Truly dead follicles, ones that have undergone complete fibrosis and been replaced by scar tissue, do not regrow hair. GHK-Cu research involves dormant or miniaturized follicles, not destroyed ones. Calling them "dead" overstates what the peptide can do and could give false hope to women whose follicle loss is already permanent.

What she got right: GHK-Cu does have plausible mechanisms for improving hair strand integrity and supporting the follicle environment through antioxidant and anti-inflammatory activity (Pickart and Margolina, 2018, Cosmetics). The circulation point is also defensible given the peptide's vascular activity documented in wound healing literature. Her framing of perimenopause as a distinct driver of hair thinning is accurate. Estrogen decline accelerates the shift of follicles into the telogen (resting) phase, which is well documented in dermatology literature (Blume-Peytavi et al., 2011, British Journal of Dermatology). She's right that this is common and worth addressing. She just oversells what one peptide can do about it.

What should you actually know?

Perimenopausal hair thinning usually has multiple drivers, not one. Estrogen and progesterone decline, increased androgen sensitivity, thyroid changes, iron deficiency, and chronic stress can all contribute simultaneously. A peptide applied topically or taken systemically is not going to address a ferritin level of 12 or an undiagnosed thyroid condition. If you're losing hair in perimenopause, bloodwork comes before peptides.

GHK-Cu is available in topical serums without a prescription and in injectable or oral compounded forms through telehealth platforms. The topical evidence base, while limited, is the most established. Injectable GHK-Cu has far less human clinical data. Anyone recommending a specific dose or delivery method for hair regrowth is working well ahead of the published evidence. The video doesn't go there, which is worth noting as a positive.

• Perimenopausal hair thinning should be evaluated with labs before adding any new treatment.
• GHK-Cu has real mechanistic research but lacks large-scale RCTs in perimenopausal women specifically.
• Topical GHK-Cu serums have a more established safety profile than injectable forms for cosmetic use.
• No peptide has been approved by the FDA for hair loss treatment as of 2024.

Bottom line

This video is more responsible than most peptide content on TikTok. The creator is pointing to a compound with genuine scientific interest, not collagen water or biotin megadoses. But "wake up dead follicles" is an oversimplification that could mislead women with significant follicle loss into skipping effective treatments like topical minoxidil or hormonal evaluation. The biology is interesting. The certainty in the delivery is not earned yet.